Kevin Schuler

TriHealth, University of North Carolina at Chapel Hill

Papers

2

Total Citations

944

H-Index

2

About

Dr. Kevin Schuler is a leading gynecologic oncologist whose research has significantly advanced the surgical management of endometrial cancer. His most impactful contribution is the landmark FIRES trial, a multicentre, prospective cohort study that compared sentinel lymph node biopsy to complete lymphadenectomy for endometrial cancer staging. Published in 2017, this work has garnered over 900 citations, fundamentally changing clinical practice by demonstrating that a less invasive sentinel node approach can accurately stage disease while reducing surgical morbidity. Beyond this transformative study, Dr. Schuler has also contributed to surgical education, notably authoring a key paper on robotic surgical training programs in gynecology that has helped shape how residents and fellows acquire minimally invasive skills. His research bridges the gap between rigorous clinical evidence and practical surgical training, making him a respected figure in both academic oncology and surgical education. Through his work, Dr. Schuler has improved outcomes for women with gynecologic cancers while advancing the tools and techniques used by the next generation of surgeons.

Research Focus

Key Achievements

2
H-Index
2
Papers
944
Total Citations
472
Avg Citations/Paper
🏆 Most Cited Paper
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
904 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: TriHealth, University of North Carolina at Chapel Hill

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago